Subsequent Events |
12 Months Ended |
---|---|
Dec. 31, 2016 | |
Subsequent Events | |
Subsequent Events |
16. Subsequent Event TMRC Co. Ltd
In March 2017, the Company paid TMRC approximately $0.4 million for the production of SY-1425 active pharmaceutical ingredient under the supply management agreement with TMRC. |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business. No definition available.
|